Angiotensin-converting Enzyme Degrades Alzheimer Amyloid β-Peptide (Aβ); Retards Aβ Aggregation, Deposition, Fibril Formation; and Inhibits Cytotoxicity
Open Access
- 1 December 2001
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (51), 47863-47868
- https://doi.org/10.1074/jbc.m104068200
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Regulation of APP cleavage by α‐, β‐ and γ‐secretasesFEBS Letters, 2000
- Angiotensin converting enzyme and endothelial nitric oxide synthase DNA polymorphisms and late onset Alzheimer's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 1999
- Inhibition of β-amyloid cytotoxicity by midkineNeuroscience Letters, 1998
- The Role of APP Processing and Trafficking Pathways in the Formation of Amyloid β‐ProteinaAnnals of the New York Academy of Sciences, 1996
- In VitroGrowth of Alzheimer's Disease β-Amyloid Plaques Displays First-Order Kinetics†Biochemistry, 1996
- Self-association of β-Amyloid Peptide (1–40) in Solution and Binding to Lipid MembranesJournal of Molecular Biology, 1995
- Genetic associations with human longevity at the APOE and ACE lociNature Genetics, 1994
- Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solutionProtein Science, 1993
- Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's diseaseJournal of Molecular Biology, 1991
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.JCI Insight, 1990